Skip to main content
OpenTrials

Clinical trial condition

Metastatic Solid Tumor

Explore clinical trials studying Metastatic Solid Tumor. Study availability and eligibility vary by location and protocol.

82 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Solid Tumor trial results

Active, Not Recruiting

Study of LP-184 in Patients With Advanced Solid Tumors

NCT05933265

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +15 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Norton Healthcare, Inc. Louisville, Kentucky, United States
  • John Hopkins - The Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors

NCT03964727

Conditions
Metastatic Solid Tumor, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
  • USOR - Arizona Oncology - Glendale - Saguaro Cancer Center Glendale, Arizona, United States
  • Arizona Oncology Associates PC-HAL Goodyear, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 65 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors

NCT04419532

Conditions
Advanced Cancer, Metastatic Solid Tumor, Neoplasm Metastasis, +5 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Cincinnati Cancer Center Cincinnati, Ohio, United States
  • Princess Margaret Cancer Center Toronto, Ontario, Canada
  • National Cancer Center Hospital Chūōku, Japan
View Trial Details
Active, Not Recruiting

A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

NCT05081609

Conditions
2L+ Cervical Cancer, Advanced Solid Tumor, Female Urogenital Diseases, +27 more
Locations
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
  • Ascendis Pharma Investigational Site Springfield, Illinois, United States
  • Ascendis Pharma Investigational Site Louisville, Kentucky, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

NCT05863052

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +46 more
Locations
  • Arizona Cancer Center at the Unvieristy of Arizona Tucson, Arizona, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Monument Health Cancer Care Institute Rapid City, South Dakota, United States
View Trial Details
Active, Not Recruiting

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

NCT05479812

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +37 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation

NCT05919537

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • GenesisCare North Shore Sydney, New South Wales, Australia
  • ICON Cancer Centre South Brisbane Brisbane, Queensland, Australia
  • Southern Oncology Clinical Research Unit Adelaide, South Australia, Australia
  • Cabrini Health Malvern, Victoria, Australia
View Trial Details

Related conditions